CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,377 | -14.9% | 31,170 | -2.2% | 0.01% | -14.3% |
| Q2 2023 | $428,198 | -28.7% | 31,860 | -12.1% | 0.01% | -30.0% |
| Q1 2023 | $600,859 | +91634.2% | 36,240 | +2.8% | 0.02% | -16.7% |
| Q4 2022 | $655 | -99.9% | 35,240 | -31.4% | 0.02% | -7.7% |
| Q3 2022 | $659,000 | +83.1% | 51,380 | 0.0% | 0.03% | +100.0% |
| Q2 2022 | $360,000 | -15.5% | 51,380 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $426,000 | – | 51,380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |